SSRIs: suicide risk and withdrawal – (06-23-03)By
SSRIs: suicide risk and withdrawal
Wow. GlaxoSmithkline withheld info from the UK’s regulatory agency when it got approval for paroxetine (Paxil). The study basically showed no increased efficacy over placebo. My question is…this kind of behavior is rampant here in the US as well. How on Earth do these companies not get shut down by the regulatory agencies? Unfortunately, I think we can all guess at the answer.
The Journal : Current Issue
Do you like what you’ve read here? Would you like to read more? Join the Rantings!
Join now and receive Dr. Bogash’s Lifestyle Recommendations ebook free!
ABOUT THE AUTHOR
Since acquiring a passion for how the body works in chiropractic school, I have continued to indulge this desire by reading some 120 peer reviewed medical journals per month. I’m always learning more about how to help people avoid chronic diseases like diabetes, heart disease, dementia, osteoporosis, obesity and cancer, and pass along this information in my blog. There are currently almost 3,500 posts cataloged on almost every health topic imaginable. Click Here for more bio information
Leave a Reply
You must be logged in to post a comment.